View Author
tumor cancer patient study glioma anaplastic methylation prognostic oligodendroglioma oligodendroglial survival factor necrosis analysis chromosome status anaplastic oligodendroglial tumors genomic sample diagnosis fication eortc 1 ploss 19qloss mgmt promoter methylation treatment table trial 1.00 identi disease research outcome group cluster cimp status mutation association brain value oligodendroglial tumors hypertension glioma patients promoter anaplastic oligodendroglioma anaplastic oligodendrogliomas hybridization erasmus university rotterdam deletion signi oncol expression glioblastoma idh 1 mutation prognosis filing ampli prevalence prognostic value result oligoastrocytoma radiotherapy genomic hybridization multivariate analysis 1 p loss level ampli fication prognostic significance anaplastic oligoastrocytoma model review ratio egfr amp department phenotype eortc study 26951 egfr ampli fication j clin oncol grade level 10 loss abnormality
5 Most Recent Publications
|
A hypermethylated phenotype is a better predictor of survival than MGMT methylation in anaplastic oligodendroglial brain tumors: A report from EORTC study 26951
(Article)
Bent, M.J. van den Gravendeel, A.M. French, P.J. Gorlia, T. Kros, J.M. Lapre, L. Wesseling, P. Teepen, J.L.J.M. Idbaih, A. Sanson, M. Sillevis Smitt, P.A.E. |
2011-11-15
|
|
Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951
(Article)
Idbaih, A. Dalmasso, C. Delattre, O. Mokhtari, K. Sanson, M. Bent, M.J. van den Hoang-Xuan, K. Kouwenhoven, M.C.M. Jeuken, J. Carpentier, C. Gorlia, T. Kros, J.M. French, P.J. Teepen, J.L.J.M. Broët, P. |
2011-06-01
|
|
Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951
(Article)
Kouwenhoven, M.C.M. Gorlia, T. Vandenbos, F. Grisold, W. Sipos, L. Mirimanoff, R.O. Vecht, C.J. Allgeier, A. Lacombe, D. Bent, M.J. van den Kros, J.M. Ibdaih, A. Brandes, A. Bromberg, J.E.C. Mokhtari, K. Duinen, S.G. van Teepen, J.L.J.M. Wesseling, P. |
2009-12-01
|
|
Chromosome 1p loss evaluation in anaplastic oligodendrogliomas
(Article)
Idbaih, A. Kouwenhoven, M.C.M. Hoang-Xuan, K. Jeuken, J. Carpentier, C. Gorlia, T. Kros, J.M. French, P.J. Teepen, J.L.J.M. Delattre, O. Bent, M.J. van den |
2008-08-01
|
|
Hypertension as a risk factor for glioma? Evidence from a population-based study of comorbidity in glioma patients.
(Article)
Houben, M.P.W.A. Louwman, W.J. Tijssen, C.C. Teepen, J.L.J.M. Duijn, C.M. van Coebergh, J.W.W. |
2004-08-01
|
